MS Pharma Partners With Mabxience For Bevacizumab In MENA Region

Follows Agreement With Alvion For Rosuvastatin/Ezetimibe In MENA

MENA
MS Pharma is ready to commercialize bevacizumab and rosuvastatin/ezetimibe in the Middle East and North Africa region • Source: Alamy

More from Biosimilars

More from Products